Contract Notice Detail
Summary Information
Summary Information
Base Total Price:
50,199.800000 Euro
Forbid offers above base price:
Request Reference:
61003123
Request Name:
Aquisição de OCRElizumab 300 mg/10 ml Sol inj Fr 10 ml IV ao Abrigo do AQ 2021/6
Phase:
Tendering Phase
State:
Awarded
Description:
10 frascos de OCRElizumab 300 mg/10 ml Sol inj Fr 10 ml IV
Procedure Type:
VortalGOV - Acquisition under a Framework Agreement (via Direct Award)
Lot Name
Lot Base Price
Expected Duration
O1030 - OCRELIZUMAB [300 MG/ 10 ML; SOL INJ; FRS]
50,199.800000 Euro
30
(
Days
)
Object of the Contract
Object of the Contract
Type of Contract:
Supplies Acquisition
Main Object CPV Main Category:
Estrada Carlos Lima Costa Nº2, 2600-009 Vila Franca de Xira Vila Franca de Xira Lisboa PORTUGAL
CPV Main Vocabulary
33600000-6 - Pharmaceutical products
CPV Supplementary Vocabulary
Additional Classifications List
Scheduling
Scheduling
Request online publishing date:
9/7/2023 11:37 AM
(UTC +1 hour)
National official publishing date and time (DR):
12/23/2020 12:00 AM
(UTC 0 hours)
Due datetime for receiving replies:
9/11/2023 5:00 PM
(UTC +1 hour)
Financial Settings
Financial Settings
Define Advance Payments?
No
Define Warranties?
No
Contract Documents
Contract Documents
Document Name
Description
Doc Classification
Convite_HVFX_61003123_signed.pdf
Convite_HVFX_61003123_signed.pdf
Download
Anexo_IV_Formulario_Resposta_61003123.xlsx
Anexo_IV_Formulario_Resposta_61003123.xlsx
Download
CE_2021_6_signed.pdf
CE_2021_6_signed.pdf
Download
Object of contract
This contract is subject to renewal?
No
The procurement is related to a project and/or programme financed by European Union funds?
No
Legal, economic, financial and technical information
Suitability to persue the professional activity,including requirements relating to enrolement on professional or trade registers - List and brief description
NA
The contract is reserved to sheltered workshops and economic operators aiming at the social and professional integration of disabled or disadvantaged persons?
No
Questionnaire
Questionnaire
1
Questionário
1.1
Lote 1
Section for Lot - O1030 - OCRELIZUMAB [300 MG/ 10 ML; SOL INJ; FRS]
1.1.1
Lote 1
Bill of Quantities
*
(Os valores indicados não incluem o IVA)
Solicitou requisitos adicionais nesta lista de preços.
Preço Total
Total without VAT
0,000000
EUR
Cód. Artigo
Referência Interna
Descrição
Qt
Unidade
Preço Unitário
Preço Total
Reference
O1030
Internal Reference
Description
OCRELIZUMAB [300 MG/ 10 ML; SOL INJ; FRS]
Qty
10,000000
Unit
UN
Price per Unit
Total
Comentários do Comprador:
500233810 | Roche - Farmacêutica Química, Lda. | CPA:2021006/150/0322 | NºAIM:5737523;
Public Messages
Public Messages
Type
Reference
Subject
Date
No items found...